Welcome to our dedicated page for Thc Therapeutics news (Ticker: THCT), a resource for investors and traders seeking the latest updates and insights on Thc Therapeutics stock.
THC Therapeutics, Inc. (THCT) generates news that reflects its evolution from a technology-focused cannabis company into a portfolio operator in the legal and regulated cannabis industry. Company press releases highlight acquisitions, strategic agreements, product development milestones, and shifts in business strategy.
Recent news emphasizes THCT’s roll-up strategy in cannabis. The company has announced the acquisition of The Headquarters Group, Inc., a Medford, Oregon–based holding company with subsidiaries in genetics, cultivation, extraction, distribution, nutrients, and cannabis-related real estate. It has also reported acquiring STHoldings Group LLC, the parent of SugarTop Buddery, a vertically licensed cannabis company based in Eugene, Oregon with operations across cultivation, processing, wholesale, and retail.
Earlier releases focus on the development of THCT’s patented dHydronator® sanitizing herb dryer, including completion of the consumer model design, work on a commercial model, and laboratory testing to validate drying and sanitizing performance. Other announcements describe consulting and advisory relationships intended to identify acquisition targets in cannabis and psychedelics, explore modern healthcare-related opportunities, and support investor relations and corporate communications.
Investors and observers following THCT news can expect updates on acquisitions and portfolio expansion, progress related to the dHydronator® technology, exploratory initiatives such as a proposed THCT Silver precious metals subsidiary, and strategic partnerships in cannabis, wellness, and related industries. This news feed offers a centralized view of how THC Therapeutics presents its business direction, portfolio development, and strategic priorities over time.
THC Therapeutics, Inc. (THCT) announced its partnership with Milestone Management Services to enhance corporate communications and investor awareness. Milestone's CEO emphasized the growing investor interest in sectors like cannabis and technology. Brandon Romanek, CEO of THCT, highlighted that this collaboration will improve deal flow and capital raising efforts. The company is leveraging its patented dHydronator technology, which significantly reduces cannabis drying time, and is actively seeking strategic partnerships to increase shareholder value.
THC Therapeutics, Inc. (THCT) has successfully acquired significant amounts of physical silver at a low premium above spot price, leveraging the Founder & Chairman’s extensive experience in the precious metals market.
Brandon Romanek, with 15 years in the industry, emphasized the opportunity to purchase physical silver amid market manipulation by major banks. The company aims to increase its holdings, anticipating a shift towards physical silver trading. This acquisition aligns with THCT's strategy to enhance its precious metals and digital currency assets, positioning the firm well in the evolving market.
THC Therapeutics, Inc. (THCT) has joined the Las Vegas Medical Marijuana Association (LVMMA) to enhance its growth strategy by leveraging connections within the cannabis industry. The company plans to raise up to $75 million through a Reg A+ offering to fund its expansion. CEO Parker Mitchell expressed enthusiasm about the opportunities this association will bring. THC Therapeutics focuses on the dHydronator®, a technology that significantly reduces cannabis drying time from 10-14 days to less than 14 hours, while also exploring partnerships in cannabis-testing and wellness sectors.